Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart

Edith Renaud-Gabardos (1) , Florence Tatin (1) , Fransky Hantelys (1) , Benoît Lebas (1) , Denis Calise (1) , Oksana Kunduzova (1) , Bernard Masri (2) , Françoise Pujol (1) , Pierre Sicard (3) , Philippe Valet (1) , Jérôme Roncalli (4) , Xavier Chaufour (5) , Barbara Garmy-Susini (6) , Angelo Parini (5) , Anne-Catherine Prats (1)

1 I2MC - Institut des Maladies Métaboliques et Cardiovasculaires
2 Hormones, facteurs de croissance et physiopathologie vasculaire
3 ACRI-ST - Analytic and Computational Research, Inc. - Earth Sciences
4 Service de cardiologie [Toulouse]
5 I2MR - Institut de médecine moléculaire de Rangueil
6 INSERM - Institut National de la Santé et de la Recherche Médicale

Domains: Life Sciences [q-bio]; Life Sciences [q-bio]; Biochemistry, Molecular Biology; Molecular biology; Life Sciences [q-bio]; Cellular Biology

Edith Renaud-Gabardos, Florence Tatin, Fransky Hantelys, Benoît Lebas, Denis Calise, et al.. Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart. Molecular Therapy, 2018, 26 (3), pp.902-916. ⟨10.1016/j.ymthe.2017.11.007⟩. ⟨hal-02924122⟩